DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Propantheline bromide
Propantheline bromide
United States Patent Office
Muscarinic Acetylcholine Receptor
NINDS Custom Collection II
Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017
Effect of Diazepam and Hyoscine Butylbromide on Response to Secretin and Cholecystokinin-Pancreozymin in Man
PROPANTHELINE BROMIDE Tablets USP Rx Only DESCRIPTION
National Code Item Name 1
1: Gastro-Intestinal System
(12) Patent Application Publication (10) Pub. No.: US 2006/0024365A1 Vaya Et Al
Federal Register/Vol. 77, No. 115/Thursday, June 14, 2012
New Zealand Data Sheet 1 Product Name 2 Qualitative
Propantheline
Nerve Disease and Bladder Control
(12) United States Patent (10) Patent No.: US 9,283,192 B2 Mullen Et Al
Topical and Systemic Anticholinergic for Treating Hyperhidrosis
Propantheline
Irritable Bowel Syndrome with Constipation in Adults: Linaclotide
Current Pharmacologic Treatments of Irritable Bowel Syndrome
Top View
2016 Equine Gastro-Intestinal Motility – a Review on Pr
A Computational Tool for Pathway-Based Rational Drug Repositioning Supplementary Information
Hyoscyamine Sulfate for the Treatment of Clinical Bradycardia In
List of Drugs for Ethiopia LIDE (Fourth Edition)
The Management of Adult Patients with Severe Chronic Small Intestinal Dysmotility Gut: First Published As 10.1136/Gutjnl-2020-321631 on 21 August 2020
Msan(2020)32
Anticholinergic Syndrome 23 William J
Bulking Agents, Antispasmodics and Antidepressants for the Treatment of Irritable Bowel Syndrome (Review)
New-Drug-Classificat
Council of Europe Committee of Ministers (Partial
HA Standard Drug Formulary (Drug List) 050218
WO 2012/059936 Al
Antisialogogue Activity of Some Oral Anticholinergic Formulations
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Pro-Banthine Tablets 3
The Medical Treatment of Ulcerative Colitis
Avon $0 Copay Drug List
Medicine Supply Notification MSN/2020/023 Propantheline Bromide (Pro-Banthine) 15Mg Tablets (Kyowa Kirin) Tier 2 – Medium Impact* Date of Issue: 28/04/2020
Enuresis and Spontaneous Cure Rate Study of 1129 Enuretics
Pathway for the Management of Hyperhidrosis
Propantheline Bromide (Pro-Banthine) 15Mg Tablets (Kyowa Kirin)
Nefopam Hydrochloride 30 Mg Film-Coated Tablets Nefopam Hydrochloride
Propantheline Bromide Tablets USP
Buscopan®) H O CH2OH O
Government Gazette Republic of Namibia
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Examining Hyperhidrosis: an Update on New Treatments Carolyn I
Or Hyperhidrosis: Oral Glycopyrronium Bromide Yrronium Bromide
Policy Statement - Management of Hyperhidrosis
Glycopyrronium Bromide for Hyperhidrosis Not Recommended
(12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
International Classification of Procedures in Medicine
ESNM16: Irritable Bowel Syndrome with Constipation in Adults: Linaclotide
Medications That May Contribute to Sexual Disorders a Guide to Assessment and Treatment in Family Practice
Evidence Review D: Management of Diverticular Disease
Download Product Insert (PDF)
Treatment Pathway for Focal Hyperhidrosis in Primary Care
Presented By: Dr. Joohee Pradhan
II. Drug Suppressing the Cholinergic Activity (Anticholinergics = Parasympatholytics)
Treated for One Year with Anticholinergic Drugs
Transit Time
Generic-Centric Formulary
Appendix PSYCHIATRIC SIDE EFFECTS of MEDICAL DRUGS PSYCHIATRICSIDE EFFECTSOF MEDICALDRUGS
Medications That May Cause Dry Mouth
Ocular Effects of Pro-Banthine